Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) — Financial Flexibility Index
Drugs Made In America Acquisition II Corp. Ordinary Shares (DMII) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of $-172.75K (operating CF $-172.75K minus capex $0.00) represents 0% of total liabilities ($18.14 Million). Check Drugs Made In America Acquisition II Cor tangible equity quality to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Drugs Made In America Acquisition II Corp. Ordinary Shares Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Drugs Made In America Acquisition II Corp. Ordinary Shares across 2 annual periods. For the full cash flow conversion analysis, see DMII cash flow conversion.
Annual Financial Flexibility Index for Drugs Made In America Acquisition II Corp. Ordinary Shares (2024–2025)
Year-by-year free cash flow to debt coverage for Drugs Made In America Acquisition II Corp. Ordinary Shares. Explore DMII operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.06x | $-1.02 Million | $-1.02 Million | $17.80 Million | ▲ +92.5% |
| 2024 | -0.76x | $-194.30K | $-194.30K | $254.78K | — |